AP
Alnara Pharmaceuticals
Closed- Business Model
- B2B
About
Developing orally-delivered, non-systemic enzyme therapeutics for cystic fibrosis
Summary
Alnara Pharmaceuticals is a Biotech company.
Funding History
AcquisitionJul 2010
Jul 2010
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
IVI-RMA
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs
Altos Labs combines academic science and industry development to create medicines that restore ce...
San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
inVentiv HealthAcquired
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
BeiGeneIPO
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alnara-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/alnara-pharmaceuticals" alt="Alnara Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>